Nanomedicine Journal, a peer-reviewed quarterly publication by the Nanotechnology Research Center of Mashhad University of Medical Sciences published its winter issue in January 2023.
Nanomedicine Journal (NMJ), Abbreviated as Nanomed J, is a libre open access peer-reviewed quarterly publication by the Nanotechnology Research Center of Mashhad University of Medical Sciences (MUMS). Authorized by the Iranian Ministry of Science, Research and Technology as a scientific-research publication, NMJ publishes original research papers, review articles, short communications as well as letters to the editor on empirical and laboratory results, preclinical studies and clinical trials related to the applications of nanotechnology to medical sciences.
Nanomedicine Journal, Volume 10, Issue 1 was published in January 2023 and includes 8 review papers as follow:
- A comprehensive review of manganese dioxide nanoparticles and strategy to overcome toxicity
- A review study of the use of modified chitosan as a new approach to increase the preservation of blood products (erythrocytes, platelets, and plasma products): 2010-2022
- Preparation, characterization and preliminary in vivo safety evaluation of cationic nano-emulsions containing α-lipoic acid after ocular administration in NZW rabbits
- Enhanced antibacterial activity in skin exudates isolated MDR Staphylococcus aureus by γ-Al2O3 nanoparticles
- Improving the anticancer efficiency of doxorubicin by luteolin nanoemulsion: In vitro study
- Cytotoxicity and rapid uptake of antioxidants loaded onto solid lipid nanocarriers in MCF-7 and SK-Br-3 breast cancer cells
- Evaluation of the antibacterial and cytotoxic activities of Ag/ZnO nanoparticles loaded polycaprolactone/chitosan composites for dental applications
- Synthesis of a stimuli-sensitive PEGylated nanoniosomal doxorubicin for the treatment of acute myeloid leukemia: An in vitro study
For more information about the journal and also open access to introduced papers, please visit the website of the journal here.
January 07, 2023
Management
Comments
448
0 
Printable